| Age/Gender | Tumour Types | Onseta | Symptoms | Endoscopic Findings | Disease Location | Histological Findings | Treatment | Outcome |
---|---|---|---|---|---|---|---|---|---|
Kubo et al. [7] | 82/M | Non-small-cell lung cancer | 6 weeks | Diarrhoea and abdominal pain | Reddish and oedematous mucosa with loss of vascularity and ulcerations | Left side of the colon | Inflammatory infiltrates with crypt abscesses and Meissen’s plexus degeneration | Mesalazine | Improved |
Takayama et al. [8] | 89/M | Melanoma | 20Â weeks | Diarrhoea | Oedematous mucosa with increased mucous exudate and loss of vascularity | Entire colon | Inflammatory infiltrates with crypt abscesses | Mesalazine PSLb | Improved |
Takenaka et al. [9] | 45/F | Adenocarcinoma of lung | 4Â weeks | Diarrhoea and abdominal pain | Reddish and oedematous mucosa with ulceration | Left side of the colon | Inflammatory infiltrates with crypt abscesses | PSL Infliximab | Improved |
Yanai et al. [10] | 51/M | Melanoma | 9Â weeks | Bloody diarrhoea and abdominal pain | Reddish, oedematous mucosa with increased mucous exudate and loss of vascularity | Entire colon | Inflammatory infiltrates with crypt abscesses and prominent apoptosis | PSLb Infliximab | Improved |
Case 1 | 73/M | Non-small-cell lung cancer | 15Â weeks | Diarrhoea | Granular mucosa with increased mucous exudate and loss of vascularity | Entire colon | Inflammatory infiltrates with crypt abscesses | Mesalazine | Improved |
Case 2 | 78/M | Adenocarcinoma of lung | 7Â weeks | Diarrhoea and bleeding | Reddish and oedematous mucosa with loss of vascularity and ulcerations | Left side of the colon | Inflammatory infiltrates with crypt abscesses and cryptitis | PSLb | Improved |
Case 3 | 49/M | Adenocarcinoma of lung | 3Â weeks | Diarrhoea | Reddish, oedematous mucosa with increased mucous exudate and loss of vascularity | Entire colon | Inflammatory infiltrates with epithelial damage | PSLb | Improved |